A new trading day began on Monday, with Novavax, Inc (NASDAQ: NVAX) stock price down -7.62% from the previous day of trading, before settling in for the closing price of $9.31. NVAX’s price has ranged from $3.53 to $23.86 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 653.01% over the last five years. Meanwhile, its annual earnings per share averaged 76.43%. With a float of $152.99 million, this company’s outstanding shares have now reached $160.15 million.
The firm has a total of 1543 workers. Let’s measure their productivity. In terms of profitability, gross margin is 66.75%, operating margin of -33.36%, and the pretax margin is -31.6%.
Novavax, Inc (NVAX) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Novavax, Inc is 4.49%, while institutional ownership is 59.02%. The most recent insider transaction that took place on Dec 13 ’24, was worth 37,435. In this transaction Director of this company sold 4,150 shares at a rate of $9.02, taking the stock ownership to the 14,770 shares. Before that another transaction happened on Dec 31 ’24, when Company’s Director sold 5,400 for $8.00, making the entire transaction worth $43,200. This insider now owns 51,760 shares in total.
Novavax, Inc (NVAX) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.49 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 76.43% per share during the next fiscal year.
Novavax, Inc (NASDAQ: NVAX) Trading Performance Indicators
Here are Novavax, Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 0.93. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.56.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.26, a number that is poised to hit -0.60 in the next quarter and is forecasted to reach 0.12 in one year’s time.
Technical Analysis of Novavax, Inc (NVAX)
Analysing the last 5-days average volume posted by the [Novavax, Inc, NVAX], we can find that recorded value of 8.12 million was better than the volume posted last year of 6.8 million. As of the previous 9 days, the stock’s Stochastic %D was 39.57%. Additionally, its Average True Range was 0.70.
During the past 100 days, Novavax, Inc’s (NVAX) raw stochastic average was set at 21.34%, which indicates a significant decrease from 25.06% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 94.49% in the past 14 days, which was higher than the 83.28% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $8.74, while its 200-day Moving Average is $10.76. Now, the first resistance to watch is $8.88. This is followed by the second major resistance level at $9.15. The third major resistance level sits at $9.40. If the price goes on to break the first support level at $8.36, it is likely to go to the next support level at $8.11. Now, if the price goes above the second support level, the third support stands at $7.84.
Novavax, Inc (NASDAQ: NVAX) Key Stats
With a market capitalization of 1.38 billion, the company has a total of 160,185K Shares Outstanding. Currently, annual sales are 983,710 K while annual income is -545,060 K. The company’s previous quarter sales were 84,510 K while its latest quarter income was -121,300 K.
